Trial
NCT00878969
Genes, Fibrinolysis and Endothelial Dysfunction- Dialysis Aim 3
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Vanderbilt University
Collaborators
University of Washington; National Heart, Lung, and Blood Institute (NHLBI)
Condition
Oxidative Stress
Intervention
valsartan (ARB)
Why stopped
insufficient enrollment and retention
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-02-15